— Know what they know.
Not Investment Advice
Also trades as: QIA.DE (XETRA) · $vol 29M

QGEN NYSE

Qiagen N.V.
1W: +1.3% 1M: +1.2% 3M: +15.3% YTD: -1.1% 1Y: -3.4% 3Y: +13.3% 5Y: -17.4%
$44.75
+2.71 (+6.45%)
 
Weekly Expected Move ±5.6%
$40 $42 $45 $47 $50
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 52 · $9.2B mcap · 205M float · 1.29% daily turnover · Short 45% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.5 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 11.2%  ·  5Y Avg: 8.1%
Cost Advantage
60
Intangibles
65
Switching Cost
27
Network Effect
37
Scale
53
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. QGEN shows a Weak competitive edge (48.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. ROIC of 11.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$40
Low
$44
Avg Target
$48
High
Based on 4 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 17Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$44.10
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-09 UBS Doug Schenkel $52 $47 -5 +10.9% $42.38
2026-08-07 Stifel Nicolaus Daniel Arias $36 $40 +4 -4.9% $42.06
2026-08-07 Barclays — $38 $40 +2 -4.1% $41.73
2026-08-06 Jefferies — $59 $48 -11 +15.0% $41.73
2026-07-14 Berenberg Bank Harry Gillis Initiated $46 — +9.8% $41.44
2026-06-25 Kepler Capital — Initiated $39 — -0.3% $38.73
2026-06-23 Morgan Stanley — Initiated $42 — +15.8% $36.28
2026-05-18 Stifel Nicolaus — $50 $36 -14 +9.2% $32.98
2026-04-30 Deutsche Bank Jan Koch $54 $43 -11 +26.9% $33.89
2026-04-29 Barclays Luke Sergott $44 $38 -6 +11.7% $34.02
2026-04-29 Robert W. Baird — $53 $43 -10 +26.4% $34.02
2026-04-14 Barclays — $58 $44 -14 +5.0% $41.91
2026-02-09 UBS — $46 $52 +6 +2.1% $50.95
2026-02-06 Robert W. Baird Cathy Ramsey Schulte Initiated $53 — +3.6% $51.17
2026-02-06 Stifel Nicolaus — Initiated $50 — -2.4% $51.25
2026-02-06 Barclays — $55 $58 +3 +13.2% $51.23
2026-02-05 Jefferies — Initiated $59 — +15.2% $51.23
2026-01-22 Deutsche Bank Jan Koch Initiated $54 — -3.0% $55.66
2025-12-15 Barclays — $53 $55 +2 +15.5% $47.64
2025-10-02 Barclays Catherine Ramsey Schulte Initiated $53 — +8.7% $48.76
2024-10-17 HSBC Shubhangi Gupt Initiated $49 — +7.7% $45.48
2024-06-27 Wolfe Research Doug Schenkel Initiated $50 — +15.3% $43.38
2024-06-18 UBS John Sourbeer Initiated $46 — -0.1% $46.05
2021-11-03 Cowen & Co. Daniel Brennan Initiated $58 — -1.0% $58.57
2021-07-14 Bank of America Securities Derik De Bruin Initiated $52 — +3.1% $50.44
2021-07-13 Citigroup Patrick B Donnelly Initiated $58 — +18.4% $49.00
2021-07-12 Warburg Research Ulrich Huwald Initiated $46 — -6.9% $49.62

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. QGEN receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-05-06 A A-
2026-05-04 A- A
2026-02-24 B+ A-
2026-02-17 B B+
2026-02-06 B+ B
2026-01-20 None ADDED
2026-01-12 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 66 Grade A+
Profitability
66
Balance Sheet
79
Earnings Quality
73
Growth
48
Value
64
Momentum
78
Safety
80
Cash Flow
62
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. QGEN scores highest in Safety (80/100) and lowest in Growth (48/100). An overall grade of A+ places QGEN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.43
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓
Beneish M-Score
-2.63
Unlikely Manipulator
Ohlson O-Score
-8.78
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.9/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.60x
Accruals: -4.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. QGEN scores 3.43, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. QGEN scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. QGEN's score of -2.63 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. QGEN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. QGEN receives an estimated rating of AA- (score: 82.9/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). QGEN's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
22.95x
PEG
1.64x
P/S
4.39x
P/B
2.75x
P/FCF
17.99x
P/OCF
12.31x
EV/EBITDA
12.09x
EV/Revenue
4.24x
EV/EBIT
17.76x
EV/FCF
19.89x
Earnings Yield
5.08%
FCF Yield
5.56%
Shareholder Yield
6.99%
Graham Number
$26.76
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 22.9x earnings, QGEN commands a growth premium. An earnings yield of 5.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $26.76 per share, 67% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.886
NI / EBT
×
Interest Burden
0.921
EBT / EBIT
×
EBIT Margin
0.239
EBIT / Rev
×
Asset Turnover
0.359
Rev / Assets
×
Equity Multiplier
1.707
Assets / Equity
=
ROE
11.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. QGEN's ROE of 11.9% is driven by Asset Turnover (0.359), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
9.32%
Fair P/E
27.14x
Intrinsic Value
$53.46
Price/Value
0.72x
Margin of Safety
27.52%
Premium
-27.52%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with QGEN's realized 9.3% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. QGEN trades at a -28% premium to its adjusted intrinsic value of $53.46, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 27.1x compares to the current market P/E of 22.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$44.75
Median 1Y
$44.18
5th Pctile
$27.14
95th Pctile
$71.89
Ann. Volatility
29.6%
Analyst Target
$44.10
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
5,700
0.0% YoY
Revenue / Employee
$366,666
Rev: $2,089,998,999
Profit / Employee
$74,540
NI: $424,880,000
SGA / Employee
$102,398
Avg labor cost proxy
R&D / Employee
$32,898
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 20.8% 17.4% 17.7% 16.4% 14.6% 12.9% 10.4% 9.8% 9.5% 9.4% 9.4% 2.1% 2.6% 2.3% 2.7% 10.8% 11.3% 11.6% 11.9% 11.9% 11.93%
ROA 10.1% 8.5% 9.0% 8.5% 7.4% 6.8% 5.7% 5.4% 5.4% 5.5% 5.6% 1.2% 1.5% 1.4% 1.7% 6.5% 6.3% 7.1% 7.1% 7.0% 6.99%
ROIC 12.7% 12.9% 13.9% 13.3% 13.0% 11.2% 8.4% 7.9% 7.7% 7.6% 7.7% 1.4% 1.8% 1.8% 2.1% 9.0% 9.5% 10.4% 10.6% 11.2% 11.21%
ROCE 15.6% 14.7% 13.7% 13.1% 12.5% 10.7% 9.0% 8.8% 8.8% 9.6% 9.9% 3.2% 3.1% 3.2% 3.6% 11.2% 9.7% 9.1% 9.3% 9.4% 9.44%
Gross Margin 63.1% 64.2% 66.0% 64.2% 64.3% 63.8% 63.3% 63.1% 62.6% 62.1% 63.4% 7.0% 61.4% 63.9% 63.8% 62.7% 62.2% 58.7% 62.9% 63.6% 63.62%
Operating Margin 24.7% 29.7% 33.0% 23.7% 19.5% 21.0% 19.9% 21.3% 20.4% 21.7% 20.7% -46.0% 22.3% 22.9% 23.9% 22.8% 24.3% 28.5% 23.7% 24.7% 24.75%
Net Margin 24.9% 22.2% 24.7% 18.8% 16.5% 17.8% 17.5% 16.3% 16.4% 19.2% 17.6% -37.0% 19.5% 16.9% 18.8% 18.0% 24.4% 20.0% 13.8% 19.3% 19.33%
EBITDA Margin 41.0% 39.3% 41.7% 34.8% 32.5% 35.2% 36.1% 33.7% 34.3% 35.9% 36.4% -32.1% 35.5% 35.0% 35.3% 34.5% 52.1% 31.2% 30.1% 26.6% 26.56%
FCF Margin 21.9% 19.2% 22.8% 24.4% 28.4% 26.4% 21.5% 19.0% 14.1% 15.1% 18.5% 20.9% 23.4% 25.4% 25.1% 24.3% 23.0% 21.7% 19.6% 21.3% 21.32%
OCF Margin 31.7% 28.4% 31.0% 32.4% 35.5% 33.4% 29.0% 26.3% 22.1% 23.4% 26.9% 29.7% 32.2% 34.0% 34.0% 33.1% 31.8% 31.3% 29.3% 31.2% 31.16%
ROE 3Y Avg snapshot only 8.33%
ROE 5Y Avg snapshot only 9.99%
ROA 3Y Avg snapshot only 4.89%
ROIC 3Y Avg snapshot only 6.86%
ROIC Economic snapshot only 9.51%
Cash ROA snapshot only 11.11%
Cash ROIC snapshot only 15.55%
CROIC snapshot only 10.64%
NOPAT Margin snapshot only 22.45%
Pretax Margin snapshot only 21.99%
R&D / Revenue snapshot only 9.27%
SGA / Revenue snapshot only 27.91%
SBC / Revenue snapshot only 1.76%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 20.14 25.16 20.96 21.13 20.51 26.36 29.14 29.91 27.28 28.51 28.89 125.39 109.78 116.06 94.37 27.94 24.08 22.03 20.80 19.68 22.949
P/S Ratio 5.36 5.73 4.88 4.81 4.27 5.21 5.15 5.10 4.64 4.95 5.02 4.70 5.19 4.90 4.41 5.11 4.71 4.48 3.99 3.83 4.394
P/B Ratio 3.98 4.16 3.48 3.31 2.86 3.22 2.89 2.78 2.46 2.56 2.70 2.68 2.89 2.72 2.59 2.98 2.67 2.48 2.51 2.40 2.750
P/FCF 24.45 29.82 21.39 19.68 15.03 19.71 23.89 26.78 32.95 32.80 27.20 22.49 22.20 19.31 17.56 21.02 20.45 20.68 20.38 17.99 17.988
P/OCF 16.91 20.18 15.73 14.82 12.04 15.59 17.74 19.41 20.97 21.18 18.70 15.83 16.11 14.40 13.00 15.45 14.84 14.30 13.60 12.31 12.305
EV/EBITDA 13.03 15.41 12.92 12.91 11.90 14.91 15.70 15.64 14.00 14.82 15.21 27.19 28.87 27.06 24.95 15.27 12.52 12.38 12.04 12.09 12.095
EV/Revenue 5.80 6.13 5.19 5.08 4.45 5.43 5.44 5.38 4.88 5.19 5.34 4.96 5.41 5.04 4.64 5.35 4.92 4.74 4.46 4.24 4.239
EV/EBIT 16.74 20.28 16.75 16.84 15.78 20.35 22.42 22.55 20.18 21.12 21.89 66.75 66.80 60.40 51.80 20.76 18.84 18.94 18.98 17.76 17.762
EV/FCF 26.45 31.90 22.74 20.81 15.66 20.53 25.27 28.25 34.65 34.40 28.90 23.76 23.15 19.84 18.44 22.01 21.37 21.91 22.81 19.89 19.887
Earnings Yield 5.0% 4.0% 4.8% 4.7% 4.9% 3.8% 3.4% 3.3% 3.7% 3.5% 3.5% 0.8% 0.9% 0.9% 1.1% 3.6% 4.2% 4.5% 4.8% 5.1% 5.08%
FCF Yield 4.1% 3.4% 4.7% 5.1% 6.7% 5.1% 4.2% 3.7% 3.0% 3.0% 3.7% 4.4% 4.5% 5.2% 5.7% 4.8% 4.9% 4.8% 4.9% 5.6% 5.56%
PEG Ratio snapshot only 1.635
Price/Tangible Book snapshot only 25.812
EV/OCF snapshot only 13.604
EV/Gross Profit snapshot only 6.857
Acquirers Multiple snapshot only 16.733
Shareholder Yield snapshot only 6.99%
Graham Number snapshot only $26.76
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.90 1.39 2.19 2.23 1.84 2.46 2.53 2.36 3.74 1.99 1.84 1.77 2.17 3.61 3.37 1.61 2.60 3.90 3.21 2.85 2.849
Quick Ratio 1.58 1.17 1.85 1.89 1.62 2.09 2.10 1.96 2.98 1.62 1.45 1.46 1.89 3.09 2.83 1.35 2.30 3.31 2.57 2.31 2.314
Debt/Equity 0.64 0.63 0.60 0.59 0.69 0.54 0.53 0.52 0.40 0.40 0.42 0.41 0.54 0.40 0.41 0.41 0.58 0.44 0.49 0.49 0.490
Net Debt/Equity 0.33 0.29 0.22 0.19 0.12 0.13 0.17 0.15 0.13 0.12 0.17 0.15 0.12 0.07 0.13 0.14 0.12 0.15 0.30 0.25 0.253
Debt/Assets 0.32 0.32 0.31 0.31 0.35 0.30 0.30 0.30 0.25 0.25 0.26 0.25 0.31 0.25 0.25 0.25 0.32 0.26 0.28 0.28 0.279
Debt/EBITDA 1.95 2.19 2.09 2.18 2.75 2.42 2.71 2.78 2.18 2.23 2.21 3.96 5.21 3.84 3.78 2.02 2.61 2.07 2.12 2.23 2.233
Net Debt/EBITDA 0.99 1.00 0.77 0.70 0.48 0.60 0.86 0.82 0.69 0.69 0.90 1.44 1.19 0.71 1.20 0.69 0.54 0.69 1.29 1.15 1.155
Interest Coverage 13.17 12.49 13.16 12.58 11.23 9.78 8.18 7.98 8.46 9.05 9.60 3.09 3.53 3.76 4.39 14.02 15.80 15.74 13.33 12.71 12.713
Equity Multiplier 2.01 1.99 1.91 1.87 1.96 1.81 1.76 1.75 1.60 1.61 1.61 1.64 1.78 1.59 1.63 1.66 1.80 1.67 1.74 1.75 1.754
Cash Ratio snapshot only 1.365
Debt Service Coverage snapshot only 18.670
Cash to Debt snapshot only 0.483
FCF to Debt snapshot only 0.272
Defensive Interval snapshot only 567.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.38 0.37 0.39 0.37 0.35 0.34 0.32 0.32 0.31 0.32 0.32 0.33 0.32 0.34 0.35 0.36 0.32 0.35 0.37 0.36 0.359
Inventory Turnover 2.68 2.59 2.56 2.42 2.38 2.21 2.05 2.01 1.99 1.93 1.84 2.80 2.82 2.98 2.98 2.46 2.49 2.75 2.73 2.66 2.656
Receivables Turnover 6.12 5.99 6.22 6.45 6.64 6.24 5.80 6.11 6.13 5.57 5.86 5.81 5.85 5.41 5.85 5.51 5.74 5.56 5.61 5.36 5.357
Payables Turnover 8.54 7.30 8.58 8.54 8.87 7.57 8.42 8.51 9.00 8.00 9.03 12.50 13.03 12.08 14.04 9.54 9.93 10.24 10.90 9.93 9.935
DSO 60 61 59 57 55 58 63 60 60 66 62 63 62 67 62 66 64 66 65 68 68.1 days
DIO 136 141 142 151 153 165 178 181 183 189 198 130 129 122 122 148 146 133 134 137 137.4 days
DPO 43 50 43 43 41 48 43 43 41 46 40 29 28 30 26 38 37 36 33 37 36.7 days
Cash Conversion Cycle 153 152 159 165 167 176 197 198 202 209 220 164 164 160 159 176 173 163 165 169 168.8 days
Fixed Asset Turnover snapshot only 2.275
Operating Cycle snapshot only 205.6 days
Cash Velocity snapshot only 2.647
Capital Intensity snapshot only 2.804
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 30.8% 20.4% 12.0% 3.3% -0.6% -4.9% -13.6% -12.5% -12.2% -8.2% -3.0% -1.9% 0.6% 0.7% 3.3% 5.1% 5.3% 5.7% 4.8% 3.0% 2.96%
Net Income 2.1% 42.7% 20.1% 7.2% -22.2% -17.4% -34.5% -34.5% -28.3% -19.4% -4.5% -78.4% -72.0% -75.5% -72.2% 4.1% 3.4% 4.1% 3.3% 9.6% 9.62%
EPS 2.2% 44.6% 21.2% 8.1% -21.5% -14.4% -32.6% -32.6% -26.2% -19.5% -5.7% -78.3% -72.1% -74.9% -71.4% 4.2% 3.5% 4.3% 3.5% 15.1% 15.08%
FCF 49.9% 1.8% 1.2% 64.0% 28.8% 30.9% -18.4% -31.8% -56.5% -47.6% -16.9% 7.6% 67.0% 69.3% 40.7% 22.5% 3.8% -9.9% -18.5% -9.8% -9.80%
EBITDA 89.7% 25.1% 11.9% 1.8% -16.4% -12.9% -25.5% -23.6% -18.2% -11.7% -1.8% -47.9% -45.9% -46.5% -45.3% 1.0% 1.2% 1.2% 1.1% 2.9% 2.94%
Op. Income 7.4% 3.2% 1.7% 20.7% -2.1% -15.7% -37.5% -36.2% -32.7% -22.9% -3.1% -81.6% -77.9% -76.2% -71.1% 5.3% 4.4% 4.3% 3.4% 13.6% 13.58%
OCF Growth snapshot only -3.05%
Asset Growth snapshot only 1.12%
Equity Growth snapshot only -4.21%
Debt Growth snapshot only 13.82%
Shares Change snapshot only -4.75%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 14.4% 14.5% 15.3% 14.4% 13.7% 11.9% 8.8% 7.1% 4.5% 1.7% -2.1% -3.9% -4.3% -4.2% -4.7% -3.4% -2.4% -0.8% 1.6% 2.0% 2.02%
Revenue 5Y 11.2% 11.0% 11.4% 10.7% 9.9% 8.6% 6.6% 5.9% 5.5% 5.5% 5.2% 5.1% 5.3% 5.3% 5.3% 4.8% 3.9% 2.2% 0.3% -0.8% -0.83%
EPS 3Y 88.8% 39.2% 42.8% 38.6% — — — 1.9% 22.3% -0.1% -8.3% -45.9% -45.5% -44.2% -43.4% -8.5% -2.7% 2.6% 6.9% 9.3% 9.32%
EPS 5Y 38.6% 44.0% 45.4% 46.5% 38.9% 61.1% 46.1% 35.2% 31.2% 13.2% 13.1% -17.2% — — — 95.9% 18.0% 6.0% -0.1% -1.0% -0.98%
Net Income 3Y 88.0% 39.1% 42.1% 38.0% — — — 1.9% 20.2% -1.7% -9.1% -46.7% -46.2% -45.4% -44.2% -10.1% -4.4% 0.1% 4.4% 6.7% 6.69%
Net Income 5Y 37.7% 44.1% 44.8% 46.1% 38.5% 60.0% 45.0% 34.0% 29.9% 12.4% 12.4% -18.0% — — — 93.1% 16.2% 3.4% -2.2% -3.1% -3.13%
EBITDA 3Y 29.0% 21.5% 22.9% 19.9% 54.4% 50.7% 43.7% 35.1% 9.0% -1.3% -6.4% -26.0% -28.2% -25.6% -26.3% -7.0% -0.7% 0.9% 3.9% 2.7% 2.68%
EBITDA 5Y 22.3% 23.5% 23.5% 22.9% 20.1% 15.4% 11.3% 8.9% 8.0% 6.6% 6.3% -7.3% 10.3% 10.1% 9.8% 21.0% 9.2% 2.3% -1.3% -3.4% -3.38%
Gross Profit 3Y 13.3% 13.2% 14.3% 13.7% 13.3% 11.3% 7.6% 5.5% 2.7% 0.0% -3.6% -13.1% -13.2% -12.6% -13.0% -4.1% -3.2% -2.3% 0.4% 1.1% 1.06%
Gross Profit 5Y 11.5% 11.4% 11.8% 10.9% 10.1% 8.5% 6.0% 5.1% 4.4% 4.3% 4.0% -1.1% -0.8% -0.8% -0.8% 3.7% 2.8% 0.9% -1.0% -2.0% -1.97%
Op. Income 3Y 40.3% 33.2% 37.4% 33.5% — — 24.0% — 76.8% 40.1% 18.5% -47.9% -47.4% -46.3% -44.0% -9.6% -6.8% -0.7% 7.4% 9.6% 9.58%
Op. Income 5Y 32.7% 44.0% 44.0% 44.3% 38.7% 28.2% 18.8% 14.2% 12.7% 9.0% 9.5% -22.5% — — 4.3% — 46.0% 28.4% 16.3% 0.2% 0.25%
FCF 3Y 37.5% 27.5% 82.7% 1.3% 1.2% 1.2% 41.5% 47.1% 2.1% 24.5% 14.4% 6.4% -2.2% 5.1% -1.6% -3.5% -9.0% -7.2% -1.6% 5.9% 5.95%
FCF 5Y 16.8% 11.8% 15.6% 20.2% 26.8% 28.4% 25.1% 14.8% 7.8% 7.3% 32.8% 53.6% 50.5% 55.1% 27.1% 33.2% 1.2% 24.1% 11.4% 5.9% 5.87%
OCF 3Y 29.8% 21.1% 26.3% 31.8% 33.5% 29.3% 24.3% 13.6% 13.3% 0.1% -3.0% -0.9% -3.7% 1.8% -1.8% -2.7% -5.9% -2.9% 2.0% 8.0% 8.02%
OCF 5Y 16.7% 13.3% 15.2% 17.8% 20.5% 20.1% 16.1% 9.9% 5.9% 5.0% 7.9% 12.4% 13.8% 15.3% 17.6% 13.8% 17.2% 7.4% 1.5% 2.0% 2.02%
Assets 3Y 4.5% 2.3% 4.5% 4.6% 8.2% 6.3% 6.6% 6.2% 0.8% 1.4% 0.2% -1.9% 1.2% -2.5% -3.6% -1.8% 0.2% 0.0% -2.7% -2.5% -2.47%
Assets 5Y 6.9% 7.4% 8.7% 6.2% 5.0% 4.5% 4.2% 3.6% 2.2% 1.2% 1.4% 0.7% 4.0% 1.7% 1.4% 1.9% 2.6% 1.4% 0.1% -0.1% -0.06%
Equity 3Y 6.0% 5.5% 7.5% 7.6% 10.5% 11.0% 12.6% 11.4% 10.9% 10.8% 8.1% 4.6% 5.4% 4.8% 1.7% 2.2% 3.1% 2.9% -2.2% -2.5% -2.51%
Book Value 3Y 6.5% 5.6% 8.1% 8.1% 9.9% 12.3% 14.1% 13.1% 12.8% 12.6% 9.0% 6.1% 6.7% 7.0% 3.2% 4.0% 4.9% 5.4% 0.1% -0.1% -0.10%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.77 0.83 0.84 0.84 0.86 0.85 0.66 0.60 0.56 0.54 0.31 0.24 0.23 0.25 0.20 0.24 0.26 0.25 0.00 0.11 0.113
Earnings Stability 0.40 0.54 0.57 0.62 0.63 0.63 0.51 0.49 0.50 0.39 0.28 0.01 0.04 0.01 0.00 0.01 0.03 0.14 0.32 0.12 0.125
Margin Stability 0.98 0.98 0.98 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.88 0.88 0.89 0.89 0.88 0.88 0.89 0.89 0.89 0.887
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.97 0.91 0.93 0.86 0.86 0.89 0.92 0.98 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.96 0.962
Earnings Smoothness 0.00 0.65 0.82 0.93 0.75 0.81 0.58 0.58 0.67 0.79 0.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.91 0.908
ROE Trend 0.17 0.11 0.09 0.07 0.01 -0.02 -0.06 -0.07 -0.08 -0.05 -0.04 -0.10 -0.09 -0.08 -0.07 0.05 0.05 0.06 0.06 0.06 0.058
Gross Margin Trend -0.01 -0.01 -0.01 -0.02 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.16 -0.16 -0.15 -0.14 0.07 0.07 0.06 0.06 0.06 0.061
FCF Margin Trend 0.20 0.13 0.12 0.13 0.17 0.13 0.04 -0.01 -0.11 -0.08 -0.04 -0.01 0.02 0.05 0.05 0.04 0.04 0.01 -0.02 -0.01 -0.013
Sustainable Growth Rate 20.8% 17.4% 17.7% 16.4% 14.6% 12.9% 10.4% 9.8% 9.5% 9.4% 9.4% 2.1% 2.6% 2.3% 2.7% 10.8% 9.8% 10.1% 10.3% 10.3% 10.35%
Internal Growth Rate 11.2% 9.3% 9.9% 9.3% 8.0% 7.3% 6.0% 5.7% 5.7% 5.8% 5.9% 1.2% 1.6% 1.4% 1.7% 7.0% 5.8% 6.6% 6.5% 6.5% 6.45%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.19 1.25 1.33 1.43 1.70 1.69 1.64 1.54 1.30 1.35 1.55 7.92 6.82 8.06 7.26 1.81 1.62 1.54 1.53 1.60 1.599
FCF/OCF 0.69 0.68 0.74 0.75 0.80 0.79 0.74 0.72 0.64 0.65 0.69 0.70 0.73 0.75 0.74 0.74 0.73 0.69 0.67 0.68 0.684
FCF/Net Income snapshot only 1.094
OCF/EBITDA snapshot only 0.889
CapEx/Revenue 9.8% 9.2% 8.2% 8.0% 7.0% 7.0% 7.5% 7.2% 8.0% 8.3% 8.4% 8.8% 8.8% 8.7% 8.8% 8.8% 8.7% 9.7% 9.8% 9.8% 9.84%
CapEx/Depreciation snapshot only 0.880
Accruals Ratio -0.02 -0.02 -0.03 -0.04 -0.05 -0.05 -0.04 -0.03 -0.02 -0.02 -0.03 -0.08 -0.09 -0.10 -0.10 -0.05 -0.04 -0.04 -0.04 -0.04 -0.042
Sloan Accruals snapshot only 0.026
Cash Flow Adequacy snapshot only 2.507
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 0.6% 0.6% 0.7% 5.90%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.25 $0.26 $0.26 $0.26 $2.64
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 13.4% 12.8% 13.5% 13.3% 13.25%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 11.4% 12.0% 13.2% 12.1% 12.12%
Total Payout Ratio 24.5% 19.5% 18.6% 19.4% 3.8% 0.0% 0.0% 0.0% 1.4% 1.4% 88.1% 4.5% 3.4% 3.8% 3.3% 78.0% 87.5% 83.9% 1.4% 1.4% 1.38%
Div. Increase Streak — — — — — — — — — — — — — — — — 0 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.2% 0.8% 0.9% 0.9% 0.2% 0.0% 0.0% 0.0% 0.1% 0.0% 3.0% 3.6% 3.1% 3.3% 3.5% 2.8% 3.1% 3.2% 6.2% 6.3% 6.32%
Net Buyback Yield 1.2% 0.7% 0.8% 0.9% 0.2% -0.0% -0.0% -0.0% 0.0% -0.3% 2.7% 3.1% -2.1% -1.8% -2.1% -2.0% 3.1% 3.2% 6.2% 6.3% 6.32%
Total Shareholder Return 1.2% 0.7% 0.8% 0.9% 0.2% -0.0% -0.0% -0.0% 0.0% -0.3% 2.7% 3.1% -2.1% -1.8% -2.1% -2.0% 3.6% 3.8% 6.9% 7.0% 6.99%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.83 0.82 0.81 0.82 0.81 0.83 0.83 0.82 0.80 0.79 0.80 0.75 0.81 0.69 0.68 0.76 0.80 0.87 0.88 0.89 0.886
Interest Burden (EBT/EBIT) 0.92 0.92 0.92 0.92 0.91 0.90 0.88 0.87 0.88 0.89 0.90 0.68 0.72 0.73 0.77 0.93 0.94 0.94 0.93 0.92 0.921
EBIT Margin 0.35 0.30 0.31 0.30 0.28 0.27 0.24 0.24 0.24 0.25 0.24 0.07 0.08 0.08 0.09 0.26 0.26 0.25 0.24 0.24 0.239
Asset Turnover 0.38 0.37 0.39 0.37 0.35 0.34 0.32 0.32 0.31 0.32 0.32 0.33 0.32 0.34 0.35 0.36 0.32 0.35 0.37 0.36 0.359
Equity Multiplier 2.06 2.04 1.96 1.93 1.98 1.89 1.83 1.81 1.77 1.71 1.69 1.70 1.69 1.60 1.62 1.65 1.79 1.63 1.68 1.71 1.707
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.57 $2.21 $2.34 $2.24 $2.01 $1.89 $1.58 $1.51 $1.49 $1.52 $1.49 $0.33 $0.41 $0.38 $0.43 $1.71 $1.86 $2.05 $1.92 $1.97 $1.97
Book Value/Share $12.98 $13.36 $14.08 $14.28 $14.46 $15.51 $15.92 $16.21 $16.51 $17.01 $15.89 $15.34 $15.76 $16.36 $15.48 $16.07 $16.71 $18.19 $15.95 $16.16 $16.27
Tangible Book/Share $0.09 $0.51 $1.24 $1.51 $2.07 $2.55 $2.33 $2.67 $3.20 $3.60 $2.86 $2.75 $3.18 $3.84 $3.04 $2.93 $3.65 $3.33 $1.28 $1.50 $1.50
Revenue/Share $9.65 $9.71 $10.05 $9.83 $9.67 $9.58 $8.93 $8.85 $8.74 $8.78 $8.56 $8.74 $8.78 $9.07 $9.10 $9.35 $9.48 $10.06 $10.05 $10.11 $10.18
FCF/Share $2.12 $1.87 $2.29 $2.40 $2.75 $2.53 $1.92 $1.68 $1.23 $1.33 $1.58 $1.83 $2.05 $2.30 $2.29 $2.27 $2.18 $2.18 $1.96 $2.15 $2.17
OCF/Share $3.06 $2.76 $3.12 $3.19 $3.43 $3.20 $2.59 $2.32 $1.93 $2.05 $2.30 $2.59 $2.83 $3.09 $3.09 $3.09 $3.01 $3.15 $2.94 $3.15 $3.17
Cash/Share $4.12 $4.60 $5.34 $5.70 $8.20 $6.35 $5.76 $5.96 $4.54 $4.73 $3.94 $4.01 $6.61 $5.29 $4.38 $4.37 $7.74 $5.29 $3.09 $3.82 $3.85
EBITDA/Share $4.29 $3.86 $4.04 $3.87 $3.62 $3.49 $3.10 $3.04 $3.04 $3.08 $3.00 $1.60 $1.65 $1.69 $1.69 $3.28 $3.73 $3.85 $3.72 $3.54 $3.54
Debt/Share $8.36 $8.47 $8.44 $8.42 $9.95 $8.43 $8.40 $8.44 $6.63 $6.84 $6.64 $6.31 $8.57 $6.49 $6.40 $6.62 $9.74 $7.96 $7.88 $7.91 $7.91
Net Debt/Share $4.23 $3.88 $3.10 $2.72 $1.75 $2.08 $2.65 $2.49 $2.09 $2.12 $2.69 $2.30 $1.96 $1.21 $2.02 $2.25 $2.00 $2.67 $4.79 $4.09 $4.09
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.435
Altman Z-Prime snapshot only 6.668
Piotroski F-Score 7 7 8 7 5 6 6 6 6 4 6 6 3 8 8 8 8 7 6 8 8
Beneish M-Score -2.70 -2.63 -2.62 -2.76 -2.90 -2.80 -2.79 -2.67 -2.48 -2.38 -2.56 1.42 -2.84 -3.10 -2.99 -3.10 -2.58 -2.68 -2.42 -2.63 -2.626
Ohlson O-Score snapshot only -8.780
ROIC (Greenblatt) snapshot only 25.09%
Net-Net WC snapshot only $-4.21
EVA snapshot only $50799887.92
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 80.17 76.28 80.85 80.77 76.42 82.17 81.18 79.01 81.66 79.59 81.59 72.77 68.14 79.84 77.07 85.36 82.98 87.14 85.14 82.93 82.927
Credit Grade snapshot only 4
Credit Trend snapshot only -2.437
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 80
Sector Credit Rank snapshot only 80

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms